Dr. Reddy's Laboratories Limited (RDY) reported first-quarter fiscal 2025 earnings of $1 per American Depositary Share (ADS), which missed the Zacks Consensus Estimate of $1.10 per ADS. The company reported earnings of $1.01 per ADS in the year-ago quarter.Revenues grew 14% year over year to $921 million, surpassing the Zacks Consensus Estimate of $862 million. The year-over-year improvement was primarily driven by growth in global generics revenues in North America and India.Shares of Dr. Reddy’s have gain ...